We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.06B
AUM Growth
+$126M
Cap. Flow
+$31.9M
Cap. Flow %
3.01%
Top 10 Hldgs %
50.38%
Holding
252
New
48
Increased
91
Reduced
75
Closed
18

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$11.4M
2
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$6.6M
3
AAPL icon
Apple
AAPL
+$4.43M
4
SPDW icon
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
+$4.26M
5
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$2.79M

Top Sells

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$3.07M
2
IIPR icon
Innovative Industrial Properties
IIPR
+$2.65M
3
SPTM icon
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
+$2.2M
4
AVDV icon
Avantis International Small Cap Value ETF
AVDV
+$2.15M
5
AVUS icon
Avantis US Equity ETF
AVUS
+$1.58M

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.2%
2 Technology 5.81%
3 Healthcare 1.72%
4 Financials 1.08%
5 Communication Services 0.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDTX
226
DELISTED
Cidara Therapeutics
CDTX
$82.1K 0.01%
5,173
– –
EQ icon
227
Equillium
EQ
$152M
$72.1K 0.01%
99,688
-4,000
-4% -$2.38K
MFG icon
228
Mizuho Financial
MFG
$129B
$71.6K 0.01%
+20,816
New +$70.7K
ALLO icon
229
Allogene Therapeutics
ALLO
$698M
$67.7K 0.01%
21,089
+1,865
+10% +$5.29K
TEF
230
DELISTED
Telefonica
TEF
$66.1K 0.01%
+16,949
New +$68.1K
IBRX icon
231
ImmunityBio
IBRX
$8.53B
$53K 0.01%
10,555
– –
CRDF icon
232
Cardiff Oncology
CRDF
$73.1M
$46.1K ﹤0.01%
31,147
– –
VTYX
233
DELISTED
Ventyx Biosciences
VTYX
$40.3K ﹤0.01%
16,310
-2,870
-15% -$27.3K
EFTR
234
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$9.35K ﹤0.01%
800
– –
ADSK icon
235
Autodesk
ADSK
$55B
– –
-3,154
Closed -$653K
BMY icon
236
Bristol-Myers Squibb
BMY
$136B
– –
-5,609
Closed -$326K
SRXH
237
SRX Global
SRXH
$34.7M
– –
-124
Closed -$30.2K
CELH icon
238
Celsius Holdings
CELH
$8.35B
– –
-4,500
Closed -$257K
COP icon
239
ConocoPhillips
COP
$157B
– –
-6,930
Closed -$830K
CVX icon
240
Chevron
CVX
$396B
– –
-1,424
Closed -$240K
ET icon
241
Energy Transfer Partners
ET
$73.4B
– –
-55,923
Closed -$785K
FTNT icon
242
Fortinet
FTNT
$122B
– –
-52,261
Closed -$3.07M
GS icon
243
Goldman Sachs
GS
$301B
– –
-956
Closed -$309K
KYN icon
244
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
– –
-17,027
Closed -$143K
LNG icon
245
Cheniere Energy
LNG
$58.3B
– –
-2,850
Closed -$473K
MUB icon
246
iShares National Muni Bond ETF
MUB
$45.5B
– –
-2,635
Closed -$270K
OBDC icon
247
Blue Owl Capital
OBDC
$5.57B
– –
-14,237
Closed -$197K
UBER icon
248
Uber
UBER
$161B
– –
-14,493
Closed -$667K
VLO icon
249
Valero Energy
VLO
$101B
– –
-1,692
Closed -$240K
MRO
250
DELISTED
Marathon Oil Corporation
MRO
– –
-11,463
Closed -$307K
7 8 9
10
11

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Callan Capital held 252 positions worth $1.06B, up 13% from $934M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Callan Capital deployed $31.9M of net new capital in Q4 2023, opening 48 new positions and adding to 91 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 36,225 shares worth $2.09M.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, down from 90% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Innovative Industrial Properties, an estimated $2.65M trimmed.

  • Callan Capital's largest Q4 2023 buy was Avantis US Large Cap Value ETF: 36,225 shares worth $2.09M.
  • Callan Capital added most to NVIDIA in Q4 2023, an estimated $11.4M increase.
  • Callan Capital's biggest Q4 2023 reduction was Innovative Industrial Properties, cutting an estimated $2.65M.
  • Callan Capital fully exited Fortinet in Q4 2023, selling an estimated $3.07M.
  • Callan Capital's ten largest holdings make up 50% of its $1.06B portfolio in Q4 2023.
  • Callan Capital opened 48 new positions and closed 18 in Q4 2023.
  • Callan Capital's portfolio value rose 13% quarter-over-quarter to $1.06B.

Based on Callan Capital's 13F filing for Q4 2023, filed 2 Feb 2024.